血管硬化

xuè ɡuǎn yìnɡ huà
  • angiosclerosis;vascular sclerosis;hardening of the arteries
血管硬化血管硬化
  1. 血液流速的检测有助于诊断血管硬化、狭窄或阻塞等血管类疾病。

    The detection of blood flow velocity can help diagnose vascular diseases such as angiosclerosis , angiostenosis or angiemphraxis .

  2. 提示补气方药可以通过抑制胶原蛋白的合成,改善结缔组织增生和血管硬化,增加血管弹性,提高供血量,从而使衰老机体的动脉硬化症状得到改善。

    These suggested that tonifying qi prescriptions could improve connective tissue hyperplasia and angiosclerosis , increase vascular elasticity and blood-supply by inhibiting the synthesis of collagen to improve the symptoms of senil arteriectopia .

  3. 本文以AGEs交联为靶点,进行逆转老年性和糖尿病型血管硬化药物的研究。

    We designed new drugs reversing arterial stiffening in aging and diabetes targeted AGEs crosslinks .

  4. 基于AGEs交联结构逆转血管硬化化合物的设计、合成和生物活性评价

    Design , Synthesis and Screening of the Compounds Reversing Arterial Stiffening of Aging and Diabetes Based on AGEs Cross-link

  5. n-3多不饱和脂肪酸预防同种异体移植血管硬化

    Preventive Effect of n-3 Polyunsaturated Fatty Acids in Cardiac Allograft Arteriosclerosis

  6. 目的探讨脉压指数(PPI)评价高血压患者血管硬化的价值。

    Objective To evaluate vascular sclerosis of hypertensive patients with pulse pressure index ( PPI ) .

  7. 结论脑I/R后ADM表达增强,ADM表达增强与血管硬化相关。

    Conclusions The significantly increased expression of ADM after focal cerebral I / R should be related to degree of vascular sclerosis .

  8. 目前,肾保护的研究主要从防治肾小球硬化、肾间质纤维化和肾内血管硬化等方面进行,其中减少细胞外基质(ECM)过度积聚是其核心环节。

    Nowadays , studies on renal protection mainly focus on prevention and treatment of glomerular sclerosis , renal interstitial fibrosis and intrarenal vascular sclerosis etc.

  9. 结论经门静脉注射两种或两种以上供体活细胞可减轻慢性排斥反应,VEGF、ET-1的表达与血管硬化及纤维化程度呈正相关。

    Conclusions Injection of two or more kinds of donor live cells may alleviate chronic rejection via decreasing of expressions of VEGF and ET-1 in the grafts .

  10. 亚麻根富含的脂肪酸,可降低血脂,低血液中的低密度胆固醇(dl)治疗血管硬化。

    Ya ma root contains large amount of omega-3 fatty acid which can lower blood lipids and lower the LDL in the blood and can reduce arteriosclerosis .

  11. 结论:SDF-1在大鼠腹主动脉移植术后介导造血干细胞参与损伤组织的修复,并可预警移植物血管硬化以及随后的慢性移植物失功。

    Conclusion : SDF-1 participated in the repair process of rat abdominal aorta grafts by mobilizing hematopoietic stem cells to injured parts . Furthermore , SDF-1 is predictive of the subsequent development of arteriosclerosis and chronic graft dysfunction ( CGD ) .

  12. 血管硬化性病变与肝癌自发性破裂的关系

    Vascular Elasticity in Patients with Spontaneous Rupture of Hepatocellular Carcinoma

  13. 平阳霉素对血管硬化作用的实验研究

    Experiment study of effect of pingyangmycin on vascular sclerosis

  14. 血管硬化指数的测量方法与临床应用研究

    The arterial stiffness index measurement and clinical application analysis

  15. 动脉血管硬化组织的内源和外源激光荧光诊断

    Diagnosis of Atherosclerotic Plaque by Endogenous and Exogenous Fluorescence

  16. 白质内明显的小血管硬化和胶质细胞增生。

    There were obvious sclerosis of small vessel and collagenous hyperplasia in white matter ;

  17. 目的:为研究同种异体移植血管硬化,建立大白鼠颈总动脉同种异体移植血管模型。

    Transplant Artery Disease in An Rodent ModelObjective : To establish an arterial homeotransplant model .

  18. 血管硬化程度测量仪的研究和应用

    Research and application on vascular stiffness measurement

  19. 血瘀型脑血管硬化性痴呆症与内皮素、降钙素基因相关肽及一氧化氮的相关性研究

    Correlation Study on ET , CGRP and NO Levels in Vascular Dementia of Blood Stasis Type

  20. 实验结果证实肝动脉注射血管硬化剂无水乙醇后可以引起邻近汇管区肝脏局部坏死,胆管闭塞。

    Experiment result revealed obliteration of the bile duct and necrosis of the liver around the portal tract area .

  21. 目的评价应用血管硬化剂行部分性脾栓塞治疗脾功能亢进的疗效及安全性。

    Objective To assess the efficacy and safety of partial splenic embolization ( PSE ) by using hardeners in hypersplenism .

  22. 临床用血管硬化剂治疗107例次(55例),即刻止血率达93.8%。

    Totally , angiosclerotic agents were used 107 times ( 55 cases ) , and prompt hemostasis accounted for 93.8 % .

  23. 进一步分析颈动脉和脑动脉粥样硬化与传统血管硬化危险因素的相关性。

    Then analyzed the relationship between carotid atherosclerosis , cerebral atherosclerosis and the traditional vascular risk factors . Results : 1 .

  24. 衰老肾脏主要组织病理学表现为:肾皮质变薄、肾小球硬化、肾间质纤维化、肾小管萎缩及肾血管硬化。

    The histopathological features of agingkidney : renal cortical thinning , glomerulosclerosis , renal interstitial fibrosis , tubular atrophy and arteriosclerosis .

  25. 影响疗效的因素,主要与患者年龄大、病史长、周身血管硬化有关。

    Factors effecting the therapeutic outcome are the age and the status of vascular sclerosis of the patient and the medical history .

  26. 结论:脉压、脉压指数、血管硬化指数和脉搏传导速度均与冠脉粥样硬化的存在有关。

    Conclusion : Pulse wave velocity , arterial stiffness index , pulse pressure , and pulse pressure index were all higher with presence of coronary atherosclerosis .

  27. 结论:监测血液流变学指标和各项血脂指标的改变,对预防及监控心脑血管硬化性疾病,预防再复发具有重要的临床意义。

    Conclusion : The monitoring of hemodynamic value and lipid level is of significance in early clinical diagnosis , prediction and prevention of AMI and HBI .

  28. 脑血流自动调节能力较差者一般脑血管硬化严重,容易诱发高血压、脑中风等心脑血管疾病。

    The less cerebral autoregulation are arterial sclerosis of cerebral as usual , and then likely give rise to high blood pressure , stroke and other cardiovascular diseases .

  29. 香豆素类化合物具有丰富多样的生物活性如抗肿瘤、抗细菌、抗凝血、抗病毒、抗炎性及抗血管硬化,尤其是在抗菌活性方面。

    Coumarin compounds have diverse biological activities such as anti-tumor , anti-bacterial , anti-coagulant , anti-viral , anti-inflammatory , anti-vascular sclerosis , especially in terms of anti-bacterial activity .

  30. 深入研究和详细阐述了血管硬化指数这一参数测量方法,并在临床测试中进行验证、归纳和改进。

    Research and expound in detail the vascular stiffness index ( VSI ) measurement , and apply it to the clinical test to verify , analyse and improve .